Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Glycomics/Glycobiology Market - Global Forecast 2026-2032 | AI, Precision Medicine, and Biologics Demand Propel Market to USD 4.76 Billion by 2032

globenewswire.com
A Agilent Technologies is listed as a company profile in a report about the glycomics/glycobiology market. The article does not provide specific sentiment or performance data for Agilent. BKR Bruker Corporation is listed as a company profile in a report about the glycomics/glycobiology market. The article does not provide specific sentiment or performance data for Bruker. BIIB Bio-Techne Corporation is listed as a company profile in a report about the glycomics/glycobiology market. The article does not provide specific sentiment or performance data for Bio-Techne. AMZN While not explicitly mentioned, Amazon is a major cloud provider and could be indirectly impacted by the growth in AI data centers and related infrastructure discussed in the article. However, no direct mention or sentiment is provided. NVDA While not explicitly mentioned, NVIDIA is a key player in AI and AI data centers, which are drivers for the glycomics market. The article discusses AI's role, suggesting potential indirect relevance, but no direct mention or sentiment is provided. GOOGL While not explicitly mentioned, Alphabet (Google) is a major player in AI and cloud computing, which are drivers for the glycomics market. The article discusses AI's role, suggesting potential indirect relevance, but no direct mention or sentiment is provided. MSFT While not explicitly mentioned, Microsoft is a major player in AI and cloud computing, which are drivers for the glycomics market. The article discusses AI's role, suggesting potential indirect relevance, but no direct mention or sentiment is provided. QGEN QIAGEN N.V. is listed as a company profile in a report about the glycomics/glycobiology market. The article does not provide specific sentiment or performance data for QIAGEN. TMO Thermo Fisher Scientific Inc. is listed as a company profile in a report about the glycomics/glycobiology market. The article does not provide specific sentiment or performance data for Thermo Fisher. WAT Waters Corporation is listed as a company profile in a report about the glycomics/glycobiology market. The article does not provide specific sentiment or performance data for Waters. DHR Danaher Corporation (parent of SCIEX) is listed as a company profile in a report about the glycomics/glycobiology market. The article does not provide specific sentiment or performance data for Danaher.

Glycomics/Glycobiology Market - Global Forecast 2026-2032 | AI, Precision Medicine, and Biologics Demand Propel Market to USD 4.76 Billion by 2032 Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Glycomics/Glycobiology Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

The glycomics/glycobiology market research report provides strategic analysis of the technologies, applications, regional developments, and competitive factors shaping this rapidly advancing life sciences field. Valued at a projected USD 2.32 billion in 2026, the market is expected to grow at a CAGR of 12.66% and reach USD 4.76 billion by 2032. The findings support market entry planning, technology investment decisions, partnership development, and the identification of high-growth opportunities across research, diagnostics, and biopharmaceutical production.

Market Growth and Strategic Importance

Glycomics is becoming essential to understanding how glycans influence immunity, inflammation, infection, cancer biology, protein folding, cell signaling, and therapeutic performance. Analysis of N-linked glycans, O-linked glycans, glycosaminoglycans, glycolipids, and glycoproteins is increasingly relevant across:

Regulatory expectations for biologics quality are also increasing demand for glycosylation profiling, as glycan patterns can affect potency, immunogenicity, stability, serum half-life, and manufacturing consistency.

Technology and Translational Shifts

Advances in mass spectrometry, ultra-high-performance liquid chromatography, capillary electrophoresis, ion mobility separation, glycan microarrays, enzymatic labeling, and glycoproteomics are moving the field beyond structural profiling toward functional interpretation. These platforms enable deeper analysis of site-specific glycosylation, glycan isomers, disease mechanisms, immune modulation, and therapeutic outcomes.

Biopharmaceutical companies are introducing glycosylation analytics earlier in clone selection, cell culture optimization, process monitoring, biosimilar comparability, and lifecycle management. The report's technology mapping gives decision-makers a practical basis for prioritizing platforms with the strongest research, clinical, and manufacturing potential.

Artificial Intelligence and Glycoinformatics

Artificial intelligence is strengthening glycan structure prediction, mass spectrometry annotation, retention-time modeling, fragmentation analysis, biomarker classification, and multi-omics integration. AI-supported workflows can improve throughput and analytical consistency while reducing manual interpretation.

Successful implementation depends on curated spectral libraries, standardized nomenclature, validated reference materials, transparent model metrics, and rigorous experimental confirmation. Organizations evaluating AI-enabled solutions can use these insights to manage adoption risks and distinguish scalable applications from early-stage capabilities.

Regional and Country Opportunities

Industry Priorities and Competitive Readiness

Key Takeaways from This Report

Key Attributes:

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. New Revenue Opportunities

3.4. Next-Generation Business Models

3.5. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Market Dynamics

4.3.1. Key Drivers

4.3.2. Key Restraints

4.3.3. Key Opportunities

4.3.4. Key Challenges

4.4. Porter's Five Forces Analysis

4.5. PESTLE Analysis

4.6. Market Outlook

4.6.1. Near-Term Market Outlook (0-2 Years)

4.6.2. Medium-Term Market Outlook (3-5 Years)

4.6.3. Long-Term Market Outlook (5-10 Years)

4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Glycomics/Glycobiology Market, by Product Type

7.1. Introduction

7.2. Enzymes

7.2.1. Glycosidases & Neuramidases

7.2.2. Glycosyltransferases & Sialytransferases

7.2.3. Protein Sulfotransferases & Sulfatases

7.3. Instruments

7.3.1. Arrays

7.3.2. Chromatography Instruments

7.3.3. Electrophoresis Instruments

7.3.4. HPLC Columns

7.3.5. Mass Spectrometry Instruments

7.4. Kits

7.4.1. Labeling Kits

7.4.2. Purification Kits

7.5. Reagents & Chemicals

8. Glycomics/Glycobiology Market, by Applications

8.1. Introduction

8.2. Diagnostics

8.2.1. Cancer Detection

8.2.2. Genetic Disorders

8.2.3. Infectious Diseases

8.3. Therapeutics

8.3.1. Drug Delivery Systems

8.3.2. Drug Development

8.3.3. Drug Discovery

9. Glycomics/Glycobiology Market, by End-User

9.1. Introduction

9.2. Academic Research Institutes

9.3. Contract Research Organizations

9.4. Pharmaceutical & Biotechnology Companies

10. Glycomics/Glycobiology Market, by Region

10.1. Introduction

10.2. Asia-Pacific

10.3. North America

10.4. Latin America

10.5. Europe

10.6. Middle East

10.7. Africa

11. Glycomics/Glycobiology Market, by Group

11.1. Introduction

11.2. ASEAN

11.3. GCC

11.4. European Union

11.5. BRICS

11.6. G7

11.7. NATO

12. Glycomics/Glycobiology Market, by Country

12.1. Introduction

12.2. United States

12.3. Canada

12.4. Mexico

12.5. Brazil

12.6. United Kingdom

12.7. Germany

12.8. France

12.9. Russia

12.10. Italy

12.11. Spain

12.12. China

12.13. India

12.14. Japan

12.15. Australia

12.16. South Korea

13. Competitive Landscape

13.1. Market Share Analysis, 2025

13.2. Market Concentration Analysis, 2025

13.2.1. Concentration Ratio (CR)

13.2.2. Herfindahl Hirschman Index (HHI)

13.3. Recent Developments & Impact Analysis, 2025

13.4. Product Portfolio Analysis, 2025

13.5. Benchmarking Analysis, 2025

14. Company Profiles

14.1. Agilent Technologies, Inc.

14.2. AMSBIO

14.3. Asparia Glycomics

14.4. Bio-Techne Corporation

14.5. Bruker Corporation

14.6. Chemily Glycoscience

14.7. Creative Diagnostics

14.8. FUJIFILM Wako Pure Chemical Corporation

14.9. Genos Glyco

14.10. Glycan Therapeutics

14.11. GlycoDiag

14.12. glyXera GmbH

14.13. Lectenz Bio, Inc.

14.14. Ludger Ltd

14.15. Megazyme Ltd. by Neogen Corporation

14.16. Merck KGaA

14.17. New England Biolabs, Inc.

14.18. QIAGEN N.V.

14.19. RayBiotech, Inc.

14.20. Revvity, Inc.

14.21. SCIEX by Danaher Corporation

14.22. Shimadzu Corporation

14.23. Sumitomo Bakelite Co., Ltd.

14.24. Takara Bio Inc.

14.25. Thermo Fisher Scientific Inc.

14.26. Tokyo Chemical Industry Co., Ltd.

14.27. Vector Laboratories, Inc.

14.28. Waters Corporation

14.29. Z Biotech, LLC

14.30. Zacharon Pharmaceuticals, Inc.

15. Key Experts

List of Figures [17]

List of Tables [328]

For more information about this report visit https://www.researchandmarkets.com/r/lyt086

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.